Literature DB >> 29998562

CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.

Motonobu Nomura1,2, Masataka Tsuge1,2,3, Takuro Uchida1,2, Nobuhiko Hiraga1,2, Mio Kurihara1,2, Ken Tsushima1,2, Hatsue Fujino1,2, Takashi Nakahara1,2, Eisuke Murakami1,2, Hiromi Abe-Chayama2,4, Tomokazu Kawaoka1,2, Daiki Miki1,2,5, Akira Hiramatsu1,2, Michio Imamura1,2, Yoshiiku Kawakami1,2, Hiroshi Aikata1,2, Hidenori Ochi1,2,5, Yizhou Zhang1,2, Grace Naswa Makokha1,2, Clair Nelson Hayes1,2, Shinji Tanaka1,6, Kazuaki Chayama1,2,5.   

Abstract

The activation of hepatitis B virus (HBV)-related hepatitis is associated with both natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). We analyzed the association between the immune response and changes in the proportion of Pre-S deletion variants. We quantified Pre-S deleted HBV (HBV-del) and wild-type HBV (HBV-wt) DNA levels in sera obtained from HBV-infected mice and chronic hepatitis B patients. In chronic hepatitis B patients, the HBV-del proportion usually increased during or after ALT elevation but did not occur during all ALT elevations. To clarify this difference in the immunological responses, we performed in vivo analyses using HBV-infected human hepatocyte chimeric mice. Although HBV-del proportions did not change in mice with NK cell-associated hepatitis or in mice treated with entecavir, the proportions sharply increased in mice with CTL-associated hepatitis. Furthermore, the number of patients in which HBV-del proportions were greater than 5% was significantly higher in chronic hepatitis B patients than in asymptomatic carriers (P = 0.023). We identified associations between virological response in chronic hepatitis B patients and two different immune responses. The proportion of HBV-del variants could be a useful biomarker for distinguishing between chronic hepatitis and asymptomatic carriers.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  HBV; HBV DNA reduction; Pre-S deletion; hepatitis; immune response

Mesh:

Substances:

Year:  2018        PMID: 29998562     DOI: 10.1111/jvh.12970

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  3 in total

Review 1.  The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.

Authors:  Muhammad Sajid; Lianxin Liu; Cheng Sun
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 2.  The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.

Authors:  Sarun Juengpanich; Liang Shi; Yasaman Iranmanesh; Jiang Chen; Zhenzhe Cheng; Aaron Kah-Jin Khoo; Long Pan; Yifan Wang; Xiujun Cai
Journal:  Transl Oncol       Date:  2019-06-06       Impact factor: 4.243

Review 3.  Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.

Authors:  Suresh Gopi Kalathil; Yasmin Thanavala
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.